Non-alcoholic fatty liver disease: Difference between revisions

Jump to navigation Jump to search
Line 28: Line 28:


===Natural History===
===Natural History===
*The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
*The symptoms of NAFLD usually develop in the fourth decade of life.  
*The symptoms of (disease name) typically develop ___ years after exposure to ___.  
*If left untreated, Patients with NAFLD may progress to develop NASH which is more serious complication.
*If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].


===Complications===
===Complications===
*Common complications of [disease name] include:
*Common complications of NAFLD include:
**[Complication 1]
**NASH
**[Complication 2]
**Cirhosis
**[Complication 3]
**Gastro intesinal bledding
**Liver failure
**Liver cancer


===Prognosis===
===Prognosis===

Revision as of 16:28, 30 November 2017

Non-Alcoholic Fatty Liver Disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Non-alcoholic fatty liver disease On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-alcoholic fatty liver disease

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-alcoholic fatty liver disease

CDC on Non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease in the news

Blogs on Non-alcoholic fatty liver disease

Directions to Hospitals Treating Non-alcoholic fatty liver disease

Risk calculators and risk factors for Non-alcoholic fatty liver disease

Editor in Chief: Elliot Tapper, M.D., Beth Israel Deaconess Medical Center

For the patient information page on this topic, click here.

Synonyms and keywords: NASH, NAFLD, non alcoholic steatohepatitis

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Natural History

  • The symptoms of NAFLD usually develop in the fourth decade of life.
  • If left untreated, Patients with NAFLD may progress to develop NASH which is more serious complication.

Complications

  • Common complications of NAFLD include:
    • NASH
    • Cirhosis
    • Gastro intesinal bledding
    • Liver failure
    • Liver cancer

Prognosis

  • Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
  • Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
  • The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
  • [Subtype of disease/malignancy] is associated with the most favorable prognosis.
  • The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

External Links

  • NIH page on Nonalcoholic Steatohepatitis


Template:Gastroenterology


Template:WikiDoc Sources